Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

NCT04743544 is registered in ClinicalTrials.gov with Dokuz Eylul University as lead sponsor.

NCT NCT04743544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04743544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
Lead sponsor
Dokuz Eylul University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
October 31, 2022
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reactions